期刊文献+

葛根素脂质体的研制及其大鼠口服吸收 被引量:18

Preparation of Puerarin Liposome and Its Oral Absorption in Rat
下载PDF
导出
摘要 目的:制备葛根素脂质体并研究大鼠对其的口服吸收。方法:利用薄膜分散-超声法制备脂质体,利用超滤法分离游离药物测定包封率,观测脂质体的微观形态与粒径分布;HPLC法测定葛根素脂质体大鼠口服后血浆中的药物含量。结果:脂质体对葛根素的包封率为53.0%,脂质体粒子在电镜下为圆形或椭圆形,粒径范围50-300nm;葛根素脂质体对其水溶液的相对生物利用度为168%。结论:脂质体对葛根素口服吸收有显著促进作用。 Objective: To prepare puerarin liposome and study its oral absorption in rat. Methods: Liposome was prepared through the way of film dispersion-ultrasonic. Free puerarin in liposome suspension was separated from liposome through ultrafiltration, and then encapsulation ratio of liposome was determined. Micro-morphology of liposme particles was observed under electronic transmission microscope. Puerarin concentration in blood was determined by HPLC. Results:The encapsulation ratio of puerarin in liposome was 53 %, and liposome particles were global or elliptical. The diameter range of liposome particies was from 50nm to 300nm. The relative availability of puerarin liposme suspension to puerarin solution was 168%. Conclusion :Liposome as a drug cartier can enhance the oral absorption of puerarin in rat.
出处 《中药材》 CAS CSCD 北大核心 2007年第8期970-973,共4页 Journal of Chinese Medicinal Materials
关键词 葛根素 脂质体 包封率 Puerarin Liposome Encapsulation ratio
  • 相关文献

参考文献11

  • 1戴琳,余兴华.葛根素的药理作用及临床应用新进展[J].海峡药学,2004,16(6):8-10. 被引量:28
  • 2吴燕红,苏子仁,赖小平,林吉.愈风宁心片中葛根素在Beagle犬体内药动学研究[J].中成药,2006,28(2):215-218. 被引量:12
  • 3李颖,潘卫三,陈士林,杨大坚,陈新滋,徐宏喜.葛根素及其磷脂复合物在Beagle犬体内的药动学比较[J].中草药,2006,37(5):695-697. 被引量:28
  • 4Shan NM,Parikh J,Namdeo A,et al.Preparation,characterization and in vivo studies of proliposomes containing Cyclosporine A.J Nanosci Nanotechnol,2006,6(9-10):2967-73.
  • 5Degim IT,Gumusel B,Degim Z,et al.Oral administration of liposomal insulin.J Nanosci Nanotechnol,2006,6(9-10):2945-9.
  • 6Fahr A,van Hoogevest P,Kuntsche J.Lipophilic drug transfer between liposomal and biological membranes:what does it mean for parenteral and oral drug delivery? J Liposome Res,2006,16(3):281-301.
  • 7Ling SS,Magosso E,Khan NA,et al.Enhanced oral bioavailability and intestinal lymphatic transport of a hydromphilic drug using liposomes.Drug Dev Ind Pharm,2006,32(3):335-45.
  • 8Lu B.New Techniques and New Dosage Forms of Drugs.Beijing:People's Medical Publishing House,2004:129.
  • 9Florence AT,Hillery AM,Hussain N,et al.Factors affecting the oral uptake and translocation of polystyrene nanoparticles:histological and analytical evidence.J drug Targeting,1995,3(1):65.
  • 10Desai MP,Labhasetwar V,Amidon GL,et al.Gastrointestinal uptake of biodegradable microparticles:effect of particle size.Pharm:Res,1996,13(12):1838.

二级参考文献28

  • 1吴燕红,苏子仁,赖小平,姚红,林吉.愈风宁心片中葛根素在小鼠体内的药动学和生物利用度研究[J].中药新药与临床药理,2004,15(4):259-261. 被引量:19
  • 2吴燕红,苏子仁,陈建南,林吉,赖小平.从小鼠体内血药浓度时间曲线与组织分布特征评价葛根素的给药途径[J].中药新药与临床药理,2005,16(2):112-115. 被引量:18
  • 3柴象枢 王志新 等.葛根素的抗心律失常作用[J].中国药理学报,1985,6(3):166-8.
  • 4朱秀媛.葛根有效成分的代谢研究Ⅲ:葛根素的代谢及其药代动力学分析[J].药学学报,1979,14:339-341.
  • 5.中国药典一部[S].,1995.630.
  • 6苏成业 朱秀媛 李振华.葛根有效成分的代谢研究Ⅱ—14C—黄豆苷元在大鼠体内的吸收、分布和消除[J].药学学报,1979,14(3):129-133.
  • 7Keung W M,Lazo O,Kunze L,et al.Potentiation of the bioavailability of daidzin by an extract of Radix puerariae[J].Proceedings of the National Academy of Sciences of the United States of America,1996,93(9),4284-4288.
  • 8ZhuQL LüXR.The pharmacology and clinical application of puerarin[J].中草药,1997,28(11):693-696.
  • 9WuZH ZuYQ YanHY etal.The study on the solubility of puerarin and the solubilizing effect of macromolecule polymers on it[J].中草药,1999,30(1):88-89.
  • 10Institute of Materia Medica,Chinese Academy of Medical Sciences.Modern Research of Traditional Chinese Medicine(中草药现代化研究)[M].Beijing:Beijing Medical University and China Union Medical University United Press,1994.

共引文献62

同被引文献284

引证文献18

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部